Breast Implants Market Size, Share & Industry Analysis, By Product (Breast Implants and Tissue Expanders), By Material (Silicone and Saline), By Procedure (Breast Augmentation and Breast Reconstruction), By End-user (Hospitals and Specialty Clinics), and Regional Forecast, 2024-2032

The global breast implants market size was valued at USD 3.27 billion in 2023, and is projected to grow from USD 3.49 billion in 2024 to USD 5.88 billion by 2032, exhibiting a CAGR of 6.7% during the forecast period.

Cosmetic surgeries are witnessing a huge surge throughout the world. The demand for these surgeries and aesthetic implants is increasing significantly due to the importance given to physical appearance. Breast augmentation also called breast enlargement or mammoplasty, is a surgical procedure carried out to increase the breast's size using an implant or fat transfer. Many women prefer to undergo breast enlargement to enhance their physical appearance. According to the International Society of Aesthetic Plastic Surgery, breast augmentation procedures across the world increased by 3.8% during 2020-2021.

High emphasis on physical appearance, especially in the case of celebrities, and the desire to look beautiful are the primary reasons responsible for expanding the market. Moreover, the market is poised to grow owing to the product’s use in breast reconstruction surgery after breast cancer operation.

During the COVID-19 pandemic, in 2020, the market experienced a decline in its revenue due to the postponement of non-emergency surgeries. However, in 2021 and 2022, the market experienced growth due to an increase in the number of breast augmentation surgeries.

Breast Implants Market Trends

Demand for Gummy Bear Implants Increased in Recent Years

In recent years, gummy bear implants have gained much attention as compared to other types of implants. These implants have a high degree of crosslinking feature that holds the shape of the implants and prevents wrinkles. Due to this, its acceptance among the female population has increased significantly. It is an important advancement in silicone implants as they are safer than conventional implants.

Gummy bear implants were first approved by the FDA in 2012. Since that year, these implants have been fueling the breast implants market growth as they provide strength and cohesiveness. Also, they offer a more attractive alternative for women as they look more natural.

Apart from this, many plastic surgeons feel that they are more beneficial and suitable for breast reconstruction after mastectomy. It has intensified the research on gummy bear implants and is the primary reason why the demand for them has been increasing.

Moroever, the emergence of under-the-muscle breast enlargement procedure created new opportunities in the market. This type of breast augmentation procedure is minimally invasive in nature and gives more natural results. Such benefits associated with these type of breast augmentation has been fueling their demand globally.

Breast Implants Market Growth Factors

Increasing Prevalence of Breast Cancer to Fuel Need for Breast Implantation Surgeries

Breast cancer occurs in the epithelium of the ducts or lobules of the glandular breast tissues. The cases of breast cancer have been increasing at a significant growth globally.

• For instance, as per data published by the World Health Organization (WHO) in 2021, in 2020 around 2.3 million women across the globe were diagnosed with breast cancer. Furthermore, in the five years before 2020, around 7.8 milion women were diagnosed with breast cancer.

The treatment for breast cancer involves breast cancer surgery and radiation therapy. Breast surgery involves either mastectomy (entire breast removal surgery) or lumpectomy (partial mastectomy or breast-conserving surgery). In both cases, the breast structure is deformed and requires breast implantation surgery to reform the breast structure.

The increasing number of breast cancer surgery has fueled the demand for such implantations across the world.

Increasing Market Players’ Emphasis on New Product Launches to Boost Market Growth

Rising awareness regarding breast implants and their efficiency in reforming the breast structure has increased their demand among the female population. Market players have emphasized on the introduction of new implants to meet this demand and increase efficiency.

• In January 2022, Mentor Worldwide LLC received the U.S. Food and Drug Administration (FDA) approval for its breast implant MENTOR MemoryGel BOOST indicated for women aged 22 and above for breast augmentation.

Moreover, the market players have also been focusing on enhancing the breast implant procedures to make them more efficient.

• In August 2020, GC Aesthetics announced the launch of a breast delivery device to insert the silicone implants easily with minimal touch.

The above factors are expected to fuel the market's growth during the forecast period.

RESTRAINING FACTORS

Limitations Associated With Use of Implants to Restrict Market Growth

Demand for these implants has been increasing significantly across the globe. However, certain limitations are associated with using these implants, which tend to limit the market growth.

One of the prominent factors hindering the market progress is the risk of Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Rare in nature, BIA-ALCL is a type of T-cell lymphoma that usually develops around the tissue surrounding the implant. Many products are recalled from the market due to this factor. For example, in September 2019, Allergan, now acquired by AbbVie, Inc., recalled its Natrelle BIOCELL Textured Products from the market. According to the FDA, 573 cases of BIA-ALCL were reported in 2019.

Furthermore, implant ruptures and women's safety concerns have made the government re-evaluate the manufacturers’ products.

The factors above are expected to restrain the market growth.

Breast Implants Market Segmentation Analysis

By Product Analysis

Growing Availability of Customizable Implants to Foster Use of Breast Implants

The market is segmented into breast implants and tissue expanders, based on product. The breast implant segment accounted for the top market share in 2023. The increasing number of breast augmentation surgeries and commercialization of products with improved durability are the major factors attributable to the segment's growth. Moreover, the availability of implants in various shapes and customizable sizes is also anticipated to fuel the segment's growth.

A tissue expander is an implant designed to stretch the muscles and tissues to make space for the implants. An increase in the number of breast reconstruction surgeries and rapid adoption of tissue expanders for breast reconstruction will contribute to the segment's expansion during the forecast period.

By Material Analysis

Advantages Associated with Silicone Implants to Fuel Their Adoption

Based on material, the market is segmented into silicone and saline. The silicone implant segment accounted for a significant breast implants market share in 2023 and is expected to maintain its dominance during the forecast period. The dominance is attributed to the large availability of silicone implants in the market and the advantages associated with them. These implants provide a natural look and improve the overall aesthetic appearance. These factors are responsible for the increasing adoption of these implants among the female population.

Moreover, saline implants are expected to record a substantial CAGR during the forecast period. The segment's growth is attributed to the fullness and firmness provided by these implants.

By Procedure Analysis

Rising Surgery Volume to Favor Demand for Breast Augmentation Procedure

In terms of procedure, the market is segmented into breast augmentation and breast reconstruction. The breast augmentation segment accounted for the maximum share of the global market. The increasing number of breast enlargement procedures, strategic collaborations between key players, and growing influence of social media are the major factors that are anticipated to drive the segment’s growth. Furthermore, the surge in medical tourism in countries, such as Brazil and Mexico for aesthetic procedures where the services are less costly is also projected to propel the growth of the breast augmentation segment.

Although there are unclear health insurance policies for breast augmentation, reconstruction is reimbursed by many of the market payers. Active government guidelines and favourable health reimbursement policies are major factors for expanding the breast reconstruction segment. Many women have to undergo mastectomies for the treatment of breast cancer. The need for breast reconstruction after a mastectomy is also another factor expected to fuel the segment's growth.

By End-user Analysis

Increasing Trend of Medical Tourism to Fuel Admission Rate Across Hospitals

In terms of end-user, the market is categorized into hospitals and specialty clinics. The hospital segment dominated the market in 2023 and will maintain this position throughout the forecast period. Increase in the number of cosmetic surgeries in hospitals and growing trend of medical tourism are the factors attributed to the growth of this segment.

Similarly, the specialty clinic segment is projected to register remarkable growth during the forecast period. Rise in the number of standalone clinics and increasing number of cosmetic surgeons are anticipated to fuel the growth of the segment.

REGIONAL INSIGHTS

The market size in North America stood at USD 1.28 billion in 2023. High cost of the procedure as well as the implants, favorable health reimbursement for breast reconstruction, and strategic position of major manufacturers are the primary factors attributed to the expansion of the market in North America. According to the American Society for Aesthetic Plastic Surgery, 378,700 breast augmentation procedures were performed in the U.S. in 2021, which is expected to fuel the growth of the market in North America.

In Europe, the market is anticipated to grow with the high preference for silicone implants, increasing demand for cosmetic products, and active government initiatives to educate people about the various types of implants available for breast enlargement. In November 2018, POLYTECH Health & Aesthetics received the CE approval for its Polytech and B-Lite breast implants for five years, as part of the company’s recertification, which will accelerate the market growth in Europe.

Asia Pacific is projected to register significant growth in the market during the forecast period owing to the rapid adoption of cosmetic surgeries and increase in breast surgery, particularly in China and India.

Latin America is estimated to serve as a lucrative market owing to the high number of procedures performed in Brazil and growing trend of medical tourism for cosmetic procedures. In the Middle East and Africa, the market is anticipated to grow steadily owing to the increasing health spending and improving healthcare infrastructure.

List of Key Companies in Breast Implants Market

Market Players to Emphasize On Mergers and Acquisitions to Expand Their Offerings

Market players, such as Abbvie, Inc., GC Aesthetics, and POLYTECH Health & Aesthetics GmbH accounted for a significant market share in 2023. The growth of these companies was due to their increased focus on collaborations and partnerships to strengthen their position in the market. For instance, in March 2020, Abbvie, Inc. acquired Allergan, which also marked its entry into the aesthetic industry. The acquisition resulted in the inclusion of Allergan’s leading product portfolio and gave the company a prominent position in the market. Strong geographical footprints of the company and diversified product portfolio are expected to maintain the legacy of Allergan in the highly competitive market.

Other market players includse Sebbin, Sientra, Inc., ARION LABORATORIES, and others. These market players have increased their focus on new product launches and global expansion to strengthen their position in the market.

LIST OF KEY COMPANIES PROFILED:

• AbbVie Inc. (U.S.)


• GC Aesthetics (Dublin)


• Sebbin (France)


• POLYTECH Health & Aesthetics GmbH (Germany)


• ARION LABORATORIES (France)


• Sientra, Inc. (U.S.)


• HansBioMed (Korea)

KEY INDUSTRY DEVELOPMENTS:

• October 2023 –  GC Aesthetics and Bimini Health Tech partnered for enhancing breast reconstruction globally.


• December 2022 –  Sientra, Inc. announced that it had received the regulatory approval from the United Arab Emirates Ministry of Health and Prevention for the commercialization of its silicone gel breast implants in the country.


• October 2022 – GC Aesthetics announced that it had obtained the CE approval for LUNA xt, a micro-textured anatomical breast implant. With this approval, LUNA xt became the first implant approved under the European Medical Device Regulation (MDR).


• September 2022 – Sientra, Inc. announced that it had received the Saudi Food & Drug Authority’s regulatory approval for the commercialization of silicone gel implants for breast implant procedures in Saudi Arabia.


• June 2022 - GC Aesthetics announced its expansion in the Brazilian breast augmentation market.


• March 2022 – Sientra, Inc. announced that it received the regulatory approval from Health Canada for the commercialization of its silicone gel implants for breast augmentation procedures in Canada.

REPORT COVERAGE

The report provides a detailed competitive landscape. It includes the number of breast augmentation procedures and key industry developments, such as partnerships, mergers, and acquisitions. Additionally, it focuses on key points, such as new product launches in the market. Furthermore, the report covers regional analysis of the market, different segments, company profiles of key market players, market trends, and the impact of COVID-19 on the market. The report consists of quantitative and qualitative insights that are contributing to the market's growth.

Report Scope & Segmentation

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth Rate	CAGR of 6.7% from 2024-2032
Unit	Value (USD billion)
Segmentation	By Product Breast Implants Tissue Expanders
By Material Silicone Saline
By Procedure Breast Augmentation Breast Reconstruction
By End-user Hospitals Specialty Clinics
By Geography North America (by Product, by Material, by Procedure, and by End-user) U.S. Canada Europe (by Product, by Material, by Procedure, and by End-user) U.K. Germany France Italy Spain Scandinavia Rest of Europe Asia Pacific (by Product, by Material, by Procedure, and by End-user) Japan China India Australia Southeast Asia Rest of Asia- Pacific Latin America (by Product, by Material, by Procedure, and by End-user) Brazil Mexico Rest of Latin America Middle East & Africa (by Product, by Material, by Procedure, and by End-user) GCC  South Africa Rest of Middle East & Africa